Investors / United States / BroadOak Capital Partners
BroadOak Capital Partners
Investor · Brisbane, CA, United States · North America
BroadOak Capital Partners is a life sciences-focused boutique financial institution that provides direct investment through BroadOak Asset Management and investment banking services through BroadOak Partners. It serves companies across life sciences infrastructure, including tools, services, manufacturing, pharma tech and health tech.
Invests inHealthcare & Biotech
In its own wordslife scienceshealth techpharma techtoolsmanufacturingservices
Your fit with BroadOak Capital Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBroadOak Capital Partners lists 78 checked portfolio companies on its own site and is named in 6 funding rounds, 3 of them as lead. Its most frequent entry is Series A, 60% of the companies with a known first round. Its largest themes are Healthcare & Biotech (87%), Industrial & Manufacturing (6%) and AI & Machine Learning (3%). 83% of its companies are based in United States. It invests most often alongside Y Combinator, Avego and Civilization Ventures.
Counts come from funding rounds that name BroadOak Capital Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not BroadOak Capital Partners' whole history. Rounds on record name 6 companies; its own site lists 78. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 60% |
| Series B | 0% |
| Growth | 40% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 1 |
| '26 | 4 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 92th | 78 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 72th | 8% of companies confirmed by a round |
| Sector focus | 95th | 87% in its largest sector |
| Reach | 69th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Y Combinator | 3 |
| Avego | 2 |
| Civilization Ventures | 2 |
| IndieBio | 2 |
| Lerer Hippeau | 2 |
| SOSV | 2 |
| A.Capital Ventures | 1 |
| ABS Capital Partners | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers7697%
- No longer answers00%
- Points to another company23%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 87% | 15% |
| Industrial & Manufacturing | 6% | 7% |
| AI & Machine Learning | 3% | 18% |
| Education | 1% | 7% |
| Legal & Compliance | 1% | 2% |
| Consumer | 1% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare BroadOak Capital Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with BroadOak Capital Partners| Date | Company | Stage |
|---|---|---|
| 29 Oct 2026 | Series C+ | |
| 1 Jul 2026 | Series A | |
| 14 Apr 2026 | Series A Led | |
| 13 Jan 2026 | Round Led | |
| 16 Oct 2025 | Series A | |
| 20 Aug 2025 | Series C+ Led |
Round details for BroadOak Capital Partners
Amounts, full round histories and every co-investor in BroadOak Capital Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
78 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AbTherx is redefining therapeutic antibody discovery by advancing reliable, scalable transgenic technologies grounded in rigorous science. | Healthcare & Biotech | Portfolio page | ||
| Accellix automates sample preparation, flow cytometry, and data analysis to deliver rapid, standardized results on cell phenotype, enumeration, viability, identity, and purity | Healthcare & Biotech | Portfolio page | ||
| Active Motif provides products and services for epigenetics research. | Healthcare & Biotech | Portfolio page | ||
| A&G Pharmaceutical develops monoclonal antibodies against cancer-specific targets for novel therapeutic and diagnostic products | Healthcare & Biotech | Portfolio page | ||
| The company develops and manufactures raw materials for therapies, including proteins, media, and transfection reagents. | Healthcare & Biotech | Portfolio page | ||
| Allevi produces 3D bioprinters and bioinks for bioprinting applications | Healthcare & Biotech | Portfolio page | ||
| The company provides antibodies, ELISA kits, and proteins for research purposes. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Argonaut Manufacturing Services provides contract manufacturing services for pharmaceutical and life sciences products | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Avanza creates products that empower people and enrich lives through technology | Industrial & ManufacturingConsumer | Portfolio page | ||
| Avidien provides innovative liquid handling solutions for researchers and scientists | Healthcare & Biotech | Portfolio page | ||
| Axol Bioscience manufactures human induced pluripotent stem cell-derived cells and provides laboratory services for drug discovery and disease research | Healthcare & Biotech | Jan 2026Round | Page + round | |
| Azure Biosystems provides imaging systems, qPCR instruments, cell counters, and reagents for life science applications. | Healthcare & Biotech | Portfolio page | ||
| Biocare Medical designs and manufactures staining instruments and reagents for immunohistochemistry and other applications | Healthcare & Biotech | Portfolio page | ||
| Biolog provides powerful cellular analysis tools and services for solving critical problems | Healthcare & Biotech | Portfolio page | ||
| Biomerica develops, patents, manufactures and markets advanced diagnostic and therapeutic products | Healthcare & Biotech | Portfolio page | ||
| BioNex Solutions provides lab automation systems and components for various applications such as genomics, proteomics, and diagnostics. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page | ||||
| Carolina Molecular provides molecular testing services to various industries, including clinical diagnostics, discovery research, and product development. | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- broadoak.com
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 20 Aug 2025
- Companies checked
- 78
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get BroadOak Capital Partners' profile as data
Pull BroadOak Capital Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/broadoak.com
# also
GET /v1/firms/broadoak.com/portfolio
GET /v1/firms/broadoak.com/coinvestors
GET /v1/firms/broadoak.com/news